Loading
Latest filing published 30 Sept 2019 for Acasti Pharma Inc., €20k.
No signal scores available.
All filings by Jean-François Boily on record concern Acasti Pharma Inc. We count 2 filings; the first trade dates from 21 September 2018 and the latest from 26 September 2019.
The open-market record is one-sided, with 1 purchase worth €20k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2019 alone, the filings show 1 purchase and no sales.
The newest entry dates from 30 September 2019: an open-market purchase of €20k, in Acasti Pharma Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations